Westlake BioPartners Fund II L.P. 13D and 13G filings for Acelyrin, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-19 2:54 pm Purchase | 2023-05-09 | 13D | Acelyrin, Inc. SLRN | Westlake BioPartners Fund II L.P. | 9,852,020 10.100% | 9,852,020 (New Position) | Filing |